Expand CRVO Menu
CRVO MENU

CRVO Latest Press Releases

-- April 7, 2026 --

CervoMed to Provide Neflamapimod Clinical Program Update and Participate in a Panel on Biomarkers at 2026 Lewy Body Dementia Association Annual Meeting Globe Newswire 7:30 AM

-- March 19, 2026 --

CervoMed Announces New Data at the AD/PD 2026 Scientific Conference that Reinforce Neflamapimod's Positive Effects in Dementia with Lewy Bodies (DLB) in Patients without Alzheimer's Disease Co-Pathology Globe Newswire 7:30 AM

-- March 17, 2026 --

CervoMed Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Updates Globe Newswire 7:30 AM

-- March 12, 2026 --

CervoMed Announces Presentations at Upcoming AD/PD 2026 Scientific Conference Globe Newswire 7:00 AM

-- March 5, 2026 --

CervoMed to Participate in Upcoming Investor Conferences Globe Newswire 7:30 AM

-- March 4, 2026 --

CervoMed Announces Selection of Formulation and Dosing Regimen for Planned Phase 3 Trial in Patients with Dementia with Lewy Bodies Globe Newswire 7:30 AM

-- February 18, 2026 --

CervoMed's neflamapimod elected for inclusion in UK EXPERTS-ALS platform designed to prioritize promising treatments for Amyotrophic Lateral Sclerosis Globe Newswire 6:00 AM

-- February 17, 2026 --

CERo Therapeutics Announces Biotech Industry Veteran Eric Francois to Join its Board of Directors Globe Newswire 8:00 AM

-- December 4, 2025 --

CervoMed Announces Late-Breaking Data at the 18th CTAD Conference Demonstrating Neflamapimod Significantly Slows Clinical Progression in Dementia with Lewy Bodies Globe Newswire 5:00 PM

-- December 2, 2025 --

CervoMed Presents New Plasma Biomarker Data That Indicates Neflamapimod Broadly Improves Neuroinflammation and Neurodegeneration in Dementia with Lewy Bodies (DLB) Globe Newswire 7:00 AM

-- November 24, 2025 --

CervoMed to Share New Data on Neflamapimod as a Treatment for Dementia with Lewy Bodies at the 18th Clinical Trials on Alzheimer's Disease (CTAD) Conference Globe Newswire 7:00 AM
Market Data Delayed 15 Minutes